Biologic activity of adriamycin (NSC-123127) in microbial systems.
D000903:Antibiotics, Antineoplastic / Q000032:analysis / Q000494:pharmacology*; D001412:Bacillus subtilis / Q000378:metabolism; D001419:Bacteria / Q000187:drug effects*; D001681:Biological Assay; D003470:Culture Media; D003630:Daunorubicin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D013293:Enterococcus faecalis / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects; D004926:Escherichia coli / Q000187:drug effects; D005658:Fungi / Q000187:drug effects*; D006027:Glycosides / Q000032:analysis / Q000494:pharmacology; D007778:Lactobacillus / Q000187:drug effects; D015122:Mercaptopurine / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009279:Naphthacenes / Q000032:analysis / Q000494:pharmacology*; D011830:Radiation Effects; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology; D013302:Streptomyces / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D003470:Culture Media; D006027:Glycosides; D009279:Naphthacenes; D011838:Radiation-Sensitizing Agents; D015122:Mercaptopurine; D003630:Daunorubicin